Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-CA: Atorvastatin for Anthracycline Cardiotoxicity
NCT02943590Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jan 2017
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of atorvastatin in heart failure (HF), sponsored by Massachusetts General Hospital. Started Jan 2017; status: completed.
02
Drugs
atorvastatin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02943590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02943590.